Keywords: Tumors (Pre-Treatment), Brain, Glioma; Automated Machine Learning (AutoML); Hyperopt-sklearn
Motivation: Predicting survival days for glioma patients is crucial for clinical decision-making and optimizing treatment strategies.
Goal(s): This study aims to improve survival prediction for glioma patients by developing optimized machine learning models using a feature set derived from MRI data.
Approach: We preprocessed the features extracted from BraTS2020 dataset, and refined to 170 using correlation analysis. We implemented Hyperopt-sklearn for AutoML-driven model selection and hyperparameter tuning to predict survival days.
Results: The kNN model achieved F1 score of greater than 0.8 and a SGDR model performs best in the 301-400 days range, demonstrating the effectiveness and efficiency of AutoML over traditional methods.
Impact: Our results show that AutoML methods like Hyperopt-sklearn can simplify and accelerate survival prediction for glioma patients, even for researchers with minimal programming skills, thereby broadening access to advanced data-driven tools in clinical research.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords